A5005039126- Dialysis and Renal Disease Management
- Blood Pressure and Hypertension Studies
- Chronic Kidney Disease and Diabetes
- Healthcare cost, quality, practices
- Organ Donation and Transplantation
- Health Systems, Economic Evaluations, Quality of Life
- Cardiovascular Health and Disease Prevention
- Hemodynamic Monitoring and Therapy
- Renal and Vascular Pathologies
- Renal function and acid-base balance
- Central Venous Catheters and Hemodialysis
- Health Literacy and Information Accessibility
- Parathyroid Disorders and Treatments
- Mobile Health and mHealth Applications
- Tryptophan and brain disorders
- Hormonal Regulation and Hypertension
- Diabetes Treatment and Management
- Potassium and Related Disorders
- Social Media in Health Education
- Renal Diseases and Glomerulopathies
- Acute Kidney Injury Research
- Muscle and Compartmental Disorders
- Heart Failure Treatment and Management
- Electrolyte and hormonal disorders
- Global Health Care Issues
Aristotle University of Thessaloniki
2016-2025
AHEPA University Hospital
2016-2025
American Hellenic Educational Progressive Association
2025
Brigham and Women's Hospital
2025
Harvard University
2025
University of Thessaly
2015-2024
National and Kapodistrian University of Athens
2007-2024
Prince of Wales Hospital
2024
University of Zurich
2024
Chinese University of Hong Kong
2024
Historically, it takes an average of 17 years to move new treatments from clinical evidence daily practice. Given the highly effective now available prevent or delay kidney disease onset and progression, this is far too long. The time narrow gap between what we know do. Clear guidelines exist for prevention management common risk factors disease, such as hypertension diabetes, but only a fraction people with these conditions worldwide are diagnosed, even fewer treated target. Similarly, vast...
The aim of the study was to evaluate diagnostic accuracy Color Doppler US, CT Angiography (CTA), and GD-enhanced MR (MRA) compared with digital subtraction angiography (DSA) for detection renal artery stenosis in patients clinically suspected renovascular hypertension. Fifty-eight hypertension were enrolled study. All underwent CTA MRA. DSA gold standard method number arteries, existence degree stenosis, or evidence fibromuscular dysplasia. depicted 132 16 stenoses, 4 arteries US failed...
Arterial stiffness and augmentation of aortic blood pressure (BP) measured in office are known cardiovascular risk factors hemodialysis patients. This study examines the prognostic significance ambulatory brachial BP, central pulse wave velocity (PWV), heart rate-adjusted index [AIx(75)] this population. A total 170 patients underwent 48-hour monitoring with Mobil-O-Graph-NG during a standard interdialytic interval followed-up for 28.1±11.2 months. The primary end point was combination...
Around 850 million people currently are affected by different types of kidney disorders.1International Society Nephrology2019 United Nations High Level Meeting on UHC: Moving Together to Build Kidney Health worldwide; 2019.https://www.theisn.org/images/Advocacy_4_pager_2019_Final_WEB_pagebypage.pdfDate accessed: July 20, 2019Google Scholar Up 1 in 10 adults worldwide has chronic disease (CKD), which is invariably irreversible and mostly progressive. The global burden CKD increasing,...
Abstract Haemodialysis (HD) is a life-saving therapy for individuals with kidney failure. Post-filter haemodiafiltration (HDF) and high-flux HD are the most widely used treatment modalities. To date, five randomised controlled trials (RCTs) have been performed that compare all-cause cardiovascular (CV) mortality between HDF low- or in adults receiving maintenance dialysis at least one year. RCTs, meta-analyses pooled individual patient data analyses published on this topic. However, all of...
Finerenone is a novel nonsteroidal mineralocorticoid receptor (MR) antagonist (MRA) with unique pharmacological properties that offer potent and selective blockade of the MR more favorable side effect profile than spironolactone eplerenone. In large phase III clinical trial involving 13,026 patients type 2 diabetes mellitus broad spectrum chronic kidney disease, finerenone provoked substantial placebo-subtracted reduction in risk hospitalization for heart failure (HF). These preliminary...
We present the first study on influence of exercise training restless legs syndrome (RLS) in patients hemodialysis (HD). Restless has been treated pharmacologically with satisfactory results; however, side effects and rebound phenomena have reported. Intradialytic effectively counteracts uremia-induced catabolism; nevertheless, it remains unknown whether RLS undergoing HD benefit from such programs. The aims current were to evaluate effect 16-weeks aerobic severity functional capacity...
Wave reflections and arterial stiffness are independent cardiovascular risk factors in ESRD. Previous studies this population included only static recordings before after dialysis. This study investigated the variation of these indices during intra- interdialytic intervals examined demographic, clinical, hemodynamic variables related to function patients undergoing hemodialysis.Between February 2013 May 2014, a total 153 receiving maintenance hemodialysis five dialysis centers northern...
<b><i>Background/Aims:</i></b> Elevated wave reflections and arterial stiffness, as well ambulatory blood pressure (BP) are independent predictors of cardiovascular risk in end-stage-renal-disease. This study is the first to evaluate hemodialysis patients validity a new oscillometric device (Mobil-O-Graph, IEM, Germany), which estimates aortic BP, augmentation index (AIx) pulse velocity (PWV). <b><i>Methods:</i></b> Aortic SBP (aSBP), heart...